{"id":"NCT01204294","sponsor":"Boehringer Ingelheim","briefTitle":"Comprehensive Add on Study in Japan","officialTitle":"An Open Label, Randomised, Parallel Group Safety and Efficacy Study of Linagliptin (5 mg Administered Orally Once Daily) Over 52 Weeks in Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control Despite Background Mono-therapy With an Approved Antidiabetic Drug","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2010-09-17","resultsPosted":"2013-01-23","lastUpdate":"2014-03-28"},"enrollment":574,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Linagliptin","otherNames":[]},{"type":"DRUG","name":"Linagliptin","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]},{"type":"DRUG","name":"Linagliptin","otherNames":[]},{"type":"DRUG","name":"Linagliptin","otherNames":[]},{"type":"DRUG","name":"Linagliptin","otherNames":[]}],"arms":[{"label":"Bigu+Lina","type":"EXPERIMENTAL"},{"label":"Glin+Lina","type":"EXPERIMENTAL"},{"label":"Glit+Lina","type":"EXPERIMENTAL"},{"label":"SU+Lina","type":"EXPERIMENTAL"},{"label":"A-GI+Lina","type":"EXPERIMENTAL"},{"label":"SU+Met","type":"ACTIVE_COMPARATOR"},{"label":"A-GI+Met","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of the current study is to investigate the safety and efficacy of linagliptin (5mg / once daily) given for 52 weeks as add-on therapy to patients with type 2 diabetes mellitus and insufficient glycaemic control despite diet, exercise, and treatment with one approved antidiabetic drug.","primaryOutcome":{"measure":"Incidence of Adverse Events (AEs)","timeFrame":"The first drug administration through 7 days after the last drug administration, up to 382 days","effectByArm":[{"arm":"Bigu+Lina","deltaMin":69,"sd":null},{"arm":"Glin+Lina","deltaMin":55,"sd":null},{"arm":"Glit+Lina","deltaMin":62,"sd":null},{"arm":"SU+Lina","deltaMin":114,"sd":null},{"arm":"A-GI+Lina","deltaMin":71,"sd":null},{"arm":"SU+Met","deltaMin":44,"sd":null},{"arm":"A-GI+Met","deltaMin":52,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":43,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":82},"commonTop":["Nasopharyngitis","Hypoglycaemia","Fall","Upper respiratory tract inflammation","Contusion"]}}